A Phase 1, Placebo-Controlled, Multiple-Dose Escalation Trial Evaluating The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-04308515 (Part 1), And A Single Dose Pharmacokinetic Assessment Of A PF-04308515 Tablet Formulation (Part 2), In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 22 Jul 2011
At a glance
- Drugs PF 4308515 (Primary)
- Indications Inflammation
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2010 Planned end date changed from 1 Aug 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.
- 13 May 2010 Trial location (USA) identified as reported by ClinicalTrials.gov.